Clinical and laboratorial aspects of aseptic meningitis associated with MMR (measles-mumps-rubella) vaccine at a referral hospital in the State of Bahia

Clinical and laboratorial aspects of aseptic meningitis associated with MMR (measles-mumps-rubella) vaccine at a referral hospital in the State of Bahia

Bibliographic Details
Main Author:	Rita Lucena
Format:	Article
Language:	English
Published:	Academia Brasileira de Neurologia (ABNEURO) 2002-03-01
Series:	Arquivos de Neuro-Psiquiatria
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2002000100037

Similar Items

Response to Measles, Mumps and Rubella (MMR) Vaccine in Transfusion-Dependent Patients
by: Maddalena Casale, et al.
Published: (2021-05-01)

Anticancer Activity of Measles–Mumps–Rubella MMR Vaccine Viruses against Glioblastoma
by: Zumama Khalid, et al.
Published: (2023-08-01)

A review of safety and immunogenicity of a novel measles, mumps, rubella (MMR) vaccine
by: Nitin Shah, et al.
Published: (2024-12-01)

Hubungan vaksin Measles, Mumps, Rubella (MMR) dengan Kejadian Autisme
by: Elsye Souvriyanti, et al.
Published: (2016-12-01)

Improving health literacy with mumps, measles and rubella (MMR) vaccination: comparison of the readability of MMR patient-facing literature and MMR scientific abstracts
by: Tina Downey, et al.
Published: (2022-08-01)

A case of Acute Transverse Myelopathy following Measles-Mumps-Rubella (MMR) vaccination in Malaysia.
by: Mohd Fakharuddin, Mohd. Feizel Alsiddiq

Vaccines such as the MMR (Measles-Mumps-Rubella) against COVID-19 in Brazil: a missed chance?
by: ANTONIO ARAÚJO, et al.
Published: (2023-02-01)

Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients
by: Jeffrey E. Gold, et al.
Published: (2020-12-01)

Vaksinasi Measles, Mumps, dan Rubella (MMR) Sebagai Prophylaxis Terhadap COVID-19
by: Sajuni Widjaja
Published: (2020-06-01)

A study to evaluate the role of intradermal and intralesional measles, mumps, rubella (MMR) vaccine in treatment of common warts
by: Pragya Gupta, et al.
Published: (2020-01-01)

Difficulties in eliminating measles and controlling rubella and mumps: a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination.
by: Zhifang Wang, et al.
Published: (2014-01-01)

Auto-immune thrombocytopenia after Measles Mumps Rubella MMR vaccination: molecular mimicry of measles virus phosphoprotein with platelet gpIIb
by: Gerbaud Laurent, et al.
Published: (2010-05-01)

Attitudinal and demographic predictors of measles, mumps and rubella (MMR) vaccine acceptance: development and validation of an evidence-based measurement instrument.
by: Brown, K, et al.
Published: (2011)

Does Measles, Mumps, and Rubella (MMR) Vaccination Protect against COVID-19 Outcomes: A Nationwide Cohort Study
by: Epiphane Kolla, et al.
Published: (2022-11-01)

Missed Opportunities for Measles, Mumps, and Rubella (MMR) Immunization in Mesoamerica: Potential Impact on Coverage and Days at Risk.
by: Ali H Mokdad, et al.
Published: (2015-01-01)

Clinical safety issues of measles, mumps and rubella vaccines
by: M.A. Afzal, et al.
Published: (2000-01-01)

U.K. parents' decision-making about measles-mumps-rubella (MMR) vaccine 10 years after the MMR-autism controversy: a qualitative analysis.
by: Brown, K, et al.
Published: (2012)

The effectiveness of measles-mumps-rubella (MMR) vaccination in the prevention of pediatric hospitalizations for targeted and untargeted infections: A retrospective cohort study
by: Giuseppe La Torre, et al.
Published: (2017-08-01)

Science vs ‘‘scaremongering’’ over measles-mumps-rubella vaccine
by: Jacqui Wise
Published: (2001-01-01)

Measles, mumps, rubella vaccination experience in infants with egg allergy
by: Esra Hazar Sayar
Published: (2019-10-01)

Clinical trials show similar safety outcomes including febrile convulsion rates for GSK’s and Merck’s measles-mumps-rubella (MMR) vaccines
by: Md Ahsan Habib, et al.
Published: (2023-01-01)

Two cases of measles after vaccination with measles mumps and rubella combined live attenuated vaccine
by: SHEN Jinhua, et al.
Published: (2022-05-01)

Partial third nerve palsy after Measles Mumps Rubella vaccination
by: Manzotti Francesca, et al.
Published: (2010-09-01)

Neuroimmunological approach for evaluation of viral measles, mumps and rubella triple vaccine
by: William Castillo González, et al.
Published: (2019-09-01)

Efficacy of intralesional injection of mumps-measles-rubella vaccine in patients with wart
by: Abbas Zamanian, et al.
Published: (2014-01-01)

Safety of measles, mumps, and rubella vaccine in adolescents and adults in the vaccine safety Datalink
by: Kayla E. Hanson, et al.
Published: (2023-04-01)

Implementation of the preventive vacc ination program against measles, mumps, and rubella (MMR) on the example of a selected clinic in the city of Krakow
by: Marek Wojczyk, et al.
Published: (2020-06-01)

Attitudinal and demographic predictors of measles-mumps-rubella vaccine (MMR) uptake during the UK catch-up campaign 2008-09: cross-sectional survey
by: Brown, K, et al.
Published: (2011)

Intralesional injection of tuberculin purified protein derivative (PPD) versus measles, mumps, and rubella (MMR) vaccine in treatment of molluscum contagiosum: a comparative study
by: Mohamed S. Zaky, et al.
Published: (2024-01-01)

Attitudinal and demographic predictors of measles-mumps-rubella vaccine (MMR) uptake during the UK catch-up campaign 2008-09: cross-sectional survey.
by: Katrina Brown, et al.
Published: (2011-01-01)

Seroprevalence of measles, mumps, and rubella and genetic characterization of mumps virus in Khartoum, Sudan
by: Omer Adam, et al.
Published: (2020-02-01)

Measles, Mumps, Rubella serology in juvenile idiopathic arthritis
by: Heijstek MW, et al.
Published: (2008-09-01)

Quality analysis of a combined domestic vaccine for the prevention of measles, rubella and mumps
by: Anna S. Binyatova, et al.
Published: (2022-11-01)

Safety of measles, mumps, and rubella vaccine in egg allergy: in vivo and in vitro management
by: Stefania Magistà, et al.
Published: (2020-11-01)

Utility of serological screening for measles, mumps and rubella in immunocompromised patients
by: L Sticchi, et al.
Published: (2019-12-01)

Improving the Epidemiological Surveillance of Measles, Rubella and Mumps in the Russian Federation
Published: (2023-01-01)

Domestic Tetravaccine (Measles-Rubella-Mumps) – Immunization of Premature Babies
by: V. V. Semerikov, et al.
Published: (2022-09-01)

The Investigation of Seroprevalence of Measles, Rubella, Mumps, and Varicella in Medical Students
by: Şebnem ÇALIK, et al.
Published: (2017-06-01)

Inadequate Measles, Mumps, Rubella, and Varicella Immunity Among Employees
by: Stephen Ezeji-Okoye, et al.
Published: (2021-04-01)

Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children
by: Lum, L.C.S., et al.
Published: (2010)